Talk Title: “Clinical Perspectives of MSC and Optimized-MSC Therapy: The ‘Spanish Model’ Experience”

Fermin Sanchez-Guijo Professor of Hematology and Cell Therapy and Head of the Department of Hematology at the University Hospital of Salamanca, as well as Coordinator of the Gene, Cell and Transplant Therapy Area at the Biomedical Research Institute of Salamanca (IBSAL).

He holds a Degree in Medicine and Surgery (1992–1998), is a Specialist in Hematology (1999–2003), and obtained his PhD from the University of Salamanca (2004). He completed postdoctoral training at the Center for Stem Cell Biology (Prof. P. Quesenberry) in Providence, Rhode Island (2005), and has undertaken additional research stays at several international institutions.

His clinical and scientific work has focused on hematopoietic transplantation and cell and gene therapy, with active participation in national and international research networks, consortia, and expert committees. Among these, he serves on the Executive Committees of the Spanish Cell Therapy (TerCel) and Advanced Therapies (TERAV) Networks, advisory committees of the Spanish Ministry of Health and the National Transplant Organization, the JACIE Committee, the Board of the World Bone Marrow Transplant, and is the immediate-past European Vice-President of the International Society for Cell & Gene Therapy (ISCT). He has authored numerous scientific publications and has been actively involved in research projects, clinical trials, and academic activities.